Page last updated: 2024-08-24

azelnidipine and Cardiovascular Stroke

azelnidipine has been researched along with Cardiovascular Stroke in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Enomoto, S; Iwao, H; Izumi, Y; Kusuyama, T; Matsumoto, R; Nishiya, D; Omura, T; Takeuchi, K; Yoshiyama, M	1

Other Studies

1 other study(ies) available for azelnidipine and Cardiovascular Stroke

Article	Year
The long-acting Ca2+-channel blocker azelnidipine prevents left ventricular remodeling after myocardial infarction. Journal of pharmacological sciences, 2007, Volume: 103, Issue:4 Topics: Animals; Azetidinecarboxylic Acid; Blotting, Northern; Calcium Channel Blockers; Chemokine CCL2; Collagen Type I; Collagen Type III; Dihydropyridines; Echocardiography; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Male; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Organ Size; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling	2007

Article

Year

The long-acting Ca2+-channel blocker azelnidipine prevents left ventricular remodeling after myocardial infarction.

Journal of pharmacological sciences, 2007, Volume: 103, Issue:4

Topics: Animals; Azetidinecarboxylic Acid; Blotting, Northern; Calcium Channel Blockers; Chemokine CCL2; Collagen Type I; Collagen Type III; Dihydropyridines; Echocardiography; Gene Expression; Glyceraldehyde-3-Phosphate Dehydrogenases; Male; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Organ Size; Plasminogen Activator Inhibitor 1; Rats; Rats, Wistar; RNA, Messenger; Ventricular Function, Left; Ventricular Remodeling

2007